What Is (2S)-2-aminohexanoic acid

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 10, 2026

Quick Answer: (2S)-2-aminohexanoic acid, commonly known as L-norleucine, is a non-proteinogenic amino acid with a straight-chain hexanoic backbone and amino group at the 2-carbon position. The (2S) stereochemical designation indicates the naturally occurring L-configuration. This compound is widely used in genetic code expansion and protein engineering to incorporate novel amino acids into proteins through amber codon suppression, achieving 25-30% incorporation efficiency in laboratory settings.

Key Facts

L-norleucine is the straight-chain analog of leucine, lacking the characteristic methyl branch of its branched-chain counterpart, enabling distinct biophysical properties for protein engineering applications
The molecular formula is C₆H₁₃NO₂ with a molecular weight of 131.17 g/mol, making it isomeric with both L-leucine and L-isoleucine despite differing structural geometry
L-norleucine was first synthesized in the early 20th century and has become essential to genetic code expansion technologies since the 1990s, particularly in laboratory and industrial protein engineering
The compound remains non-proteinogenic, meaning it is not naturally incorporated into proteins during standard ribosomal translation, requiring engineered aminoacyl-tRNA synthetases for selective incorporation
L-norleucine is metabolically independent and resistant to standard cellular proteolysis, making it ideal for tracking protein dynamics and studying structure-function relationships in engineered proteins

Overview

(2S)-2-aminohexanoic acid, more commonly referred to as L-norleucine, is a non-proteinogenic amino acid characterized by a straight-chain hexanoic backbone with an amino group positioned at the 2-carbon atom. The (2S) stereochemical designation indicates the L-configuration or natural isomeric form, representing the biochemically active variant of 2-aminohexanoic acid. Unlike its more famous relative, leucine, L-norleucine lacks the distinctive methyl branch at the gamma carbon, making it the linear analog of this branched-chain amino acid.

This amino acid has emerged as a pivotal tool in modern molecular biology and protein engineering research. While not found naturally incorporated into proteins during standard ribosomal translation, L-norleucine has become indispensable in synthetic biology applications, particularly in the field of genetic code expansion. Scientists and researchers utilize this compound to create novel proteins with expanded functionality, enabling the incorporation of non-standard amino acids into protein structures through sophisticated molecular techniques. Its unique properties and non-proteinogenic nature make it especially valuable for investigating protein structure-function relationships and developing therapeutic proteins with enhanced capabilities.

How It Works

L-norleucine functions through specific molecular mechanisms that distinguish it from proteinogenic amino acids:

Amber Codon Suppression: The compound is incorporated into proteins through amber stop codon (UAG) suppression technology, where specially engineered aminoacyl-tRNA synthetases recognize and charge tRNAs with L-norleucine rather than terminating translation, achieving incorporation efficiencies of 25-30% in laboratory experiments.
Chemical Structure Interaction: The straight-chain aliphatic structure of L-norleucine allows it to occupy hydrophobic protein cores similarly to leucine, yet its linear geometry provides distinct spatial properties that can fine-tune protein folding, stability, and intermolecular interactions in ways that branched-chain analogs cannot.
Ribosomal Recognition: L-norleucine-charged tRNA species must compete with release factors at stop codons, a process requiring engineered aminoacyl-tRNA synthetases with altered substrate specificity and tRNA recognition properties to ensure selective incorporation at desired positions within target proteins.
Metabolic Independence: Unlike proteinogenic amino acids, L-norleucine is not synthesized through standard cellular metabolism nor degraded by common proteolytic enzymes, allowing researchers to track protein dynamics and stability independently of cellular amino acid metabolism and protein turnover pathways.
Biophysical Properties: The compound exhibits distinct hydrophobic characteristics and van der Waals interactions compared to leucine, enabling researchers to investigate how subtle differences in amino acid side-chain geometry influence protein secondary structure, tertiary folding patterns, and quaternary protein complex assembly.

Key Comparisons

Property	L-Norleucine	L-Leucine	L-Isoleucine
Molecular Formula	C₆H₁₃NO₂	C₆H₁₃NO₂	C₆H₁₃NO₂
Molecular Weight	131.17 g/mol	131.17 g/mol	131.17 g/mol
Side Chain Structure	Straight linear chain	Branched with methyl group	Branched with ethyl-methyl group
Proteinogenic Status	Non-proteinogenic	Proteinogenic (standard)	Proteinogenic (standard)
Natural Incorporation	Requires engineered machinery	Ribosomal incorporation	Ribosomal incorporation
Primary Research Use	Genetic code expansion, protein engineering	Structural biology, metabolic studies	Protein folding, stability studies

Why It Matters

Genetic Code Expansion: L-norleucine is a cornerstone technology in synthetic biology's effort to expand the standard genetic code beyond the canonical 20 amino acids, enabling the creation of novel proteins with entirely new biochemical functions previously impossible to achieve through natural or conventional protein engineering approaches.
Protein Bioengineering: Researchers leverage L-norleucine in protein design studies to create enhanced variants with improved stability, altered substrate specificity, or novel catalytic properties, producing next-generation proteins for pharmaceutical, industrial, and diagnostic applications in the rapidly growing synthetic biology sector.
Structural Investigations: The compound serves as a powerful research tool for understanding how subtle variations in amino acid side-chain geometry influence protein folding kinetics, thermal stability, protein-protein interactions, and enzyme catalytic mechanisms at atomic-level resolution.
Therapeutic Development: Scientists are exploring L-norleucine incorporation in therapeutic protein engineering to enhance pharmacokinetics, improve cellular penetration, reduce immunogenicity, and create proteins with extended half-lives and improved clinical efficacy for treating various human diseases.

As genetic code expansion technology continues to mature and gain wider adoption in academic and industrial research institutions worldwide, L-norleucine remains among the most widely utilized and well-characterized non-standard amino acids in the scientific community. Its accessibility, relative ease of incorporation through amber codon suppression, and ability to function as a leucine analog while maintaining distinct biophysical properties have established it as an essential tool in the modern synthetic biology toolkit. The ongoing development of improved incorporation systems and the expansion of codon suppression technology suggest that L-norleucine and related compounds will continue to play increasingly important roles in protein engineering, drug discovery, and fundamental biochemical research.